JPML Refuses To Consolidate Lawsuits Over Benzene in L’Oreal CeraVe, Other Acne Products
Rejected request is second failed attempt to consolidate lawsuits over benzene in acne products before one judge for pretrial proceedings.
Rejected request is second failed attempt to consolidate lawsuits over benzene in acne products before one judge for pretrial proceedings.
Potential negotiations come as the parties work to select a pool of 40 representative hair relaxer lawsuits to prepare for early bellwether test trials.
Cases will be selected from over 6,500 eligible claims, with first hair relaxer lawsuit not likely to go to trial until at least mid-2027, at the earliest.
Plaintiffs' plans call for a group of 16 hair relaxer cancer cases to be prepared for trial by the end of September 2025, while defendants' proposal would not lead to trial-ready cases until the start of 2026.
L'Oreal faces six class action lawsuits over CeraVe and other popular acne treatments, which allegedly exposed consumers to high levels of cancer-causing benzene.
Court has given the parties until January 3 to submit their competing plans for hair relaxer lawsuit bellwether trial protocols.
Manufacturers failed to turn over complete lists of hair relaxer brand names, when they were sold, and what toxic ingredients each contained, plaintiffs say.
Lawyers are meeting today with the U.S. District Judge presiding over the litigation, to provide an update on the status of hair relaxer lawsuits being pursued throughout the country.
Lawyers will report on the status of hair relaxer lawsuits involving uterine cancer, ovarian cancer and other injuries, as the Court prepares claims for trial.
As growing number of hair relaxer lawsuits continue to be filed, the Court has directed lawyers to complete all general written discovery by February 2025, and oral discovery by September 2025.